Option chain shows key data for Turnstone Biologics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Turnstone Biologics.

Turnstone Biologics (NASDAQ:TSBX) Stock, Option Chain

Turnstone Biologics

Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.

Alibaba.Fall20221.site_

Equities

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

ASTS

BABA

CING

GAMB

LLAP

SIGA

TSBX

Crude Oil Gains Over 1%; Alibaba Posts Weak Revenue

Mysterious Disappearances At Walmart

Earnings

SPRC

Nasdaq Jumps Over 2%; Walmart Earnings Top Views

Amazing Lab Results

Biotech

Health Care

Movers

General

Turnstone Biologics stock drops after Phase 1 STARLING trial data reveals mixed results for TIDAL-01 in metastatic colorectal cancer, with a 25% response rate.

Turnstone Biologics Shifts Focus To &#39;High Unmet Medical Need&#39; Cancers, Shares Initial Data From Colorectal Cancer Cell Therapy Study

Turnstone Biologics Corp

Press Releases

Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Recent Business Highlights

Turnstone Biologics Appoints William Waddill to its Board of Directors

Turnstone Biologics to Present at the 2024 Bank of America Securities Health Care Conference

Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights

Turnstone Biologics Corp. Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer

Turnstone Biologics Corp. Reports Second Quarter 2024 Financial Results and Provides Recent Business Highlights

Turnstone Biologics Announces Strategic Restructuring to Prioritize Portfolio and Extend Financial Runway

Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights

Turnstone Biologics Announces Plans to Explore Strategic Alternatives

ANNX

ARWR

PTGX

AIM ImmunoTech

Ainos

Apollomics Inc. - Class A Ordinary Shares

Apollomics

Aptorum Group Limited - Class A Ordinary Shares

Aptorum Gr

Brainstorm Cell Therapeutics Inc. - Common Stock

Brainstorm Cell

BioLineRx Ltd. - American Depositary Shares

BioLine Rx

BioRestorative Therapies, Inc. - Common Stock

BioRestorative Therapies

BioXcel Therapeutics, Inc. - Common Stock

BioXcel Therapeutics

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biofarma

Creative Medical Technology Holdings, Inc. - Common Stock

Creative Medical Tech

Cyclerion Therapeutics, Inc. - Common Stock

Cyclerion Therapeutics

Dermata Therapeutics, Inc. - Common Stock

Dermata Therapeutics

Ensysce Biosciences

Immuron Limited - American Depositary Shares

Immuron

Indaptus Therapeutics, Inc. - Common Stock

Indaptus Therapeutics

Klotho Neurosciences, Inc. - Common Stock

Klotho Neurosciences

Organovo Holdings

BiomX

Phio Pharmaceuticals Corp. - Common Stock

Phio Pharma

Portage Biotech

Plus Therapeutics

Sunshine Biopharma

Silexion Therapeutics Corp - Ordinary Shares

Silexion Therapeutics

Sensei Biotherapeutics, Inc. - Common Stock

Sensei Biotherapeutics

XTL Biopharmaceuticals Ltd. - American Depositary Shares

Comments

Turnstone Biologics

Turnstone Biologics (TSBX) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga